Trial Information

Summary: Pre-Surgical EPS Biomarkers as Predictors of Recurrence

You have been asked to participate in this research study because you are going to be undergoing surgery for  prostate cancer. The purpose of this study is to evaluate the use of Expressed Prostatic Secretion (EPS) to predict prostate cancer recurrence. Participation in this study involves a one-time collection of EPS.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 7, 2008 at 2:41:58 PM